Zheng-ren Wei

MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1

Yubao Gong, Zheng-ren Wei, 2022, BMC Cancer.

Hippocampus RNA Sequencing of Pentylenetetrazole-Kindled Rats and Upon Treatment of Novel Chemical Q808

Xia Chen, Xiang Li, Qing Wang, 2022, Frontiers in Pharmacology.

SRPK1 promotes cell proliferation and tumor growth of osteosarcoma through activation of the NF-κB signaling pathway

Jianguo Liu, Chen Yang, Yubao Gong, 2021, Biological chemistry.

Predictive Study of the Active Ingredients and Potential Targets of Codonopsis pilosula for the Treatment of Osteosarcoma via Network Pharmacology

Jianguo Liu, Yubao Gong, Zheng-ren Wei, 2021, Evidence-based complementary and alternative medicine : eCAM.

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma

Yubao Gong, Zheng-ren Wei, 2021, Cancer reports.

Assessment of the chemotherapeutic potential of a new camptothecin derivative, ZBH-1205.

Jing Zhao, Hong Yu, Jiandong Tai, 2016, Archives of biochemistry and biophysics.

MiRNA-1225 Inhibits Osteosarcoma Tumor Growth and Progression by Targeting YWHAZ

Jianguo Liu, Yubao Gong, Zheng-ren Wei, 2021, OncoTargets and therapy.